Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 1,346 | 269 |
| Marketable Securities | N/A | N/A | N/A | 3 | 3 |
| Receivables | N/A | N/A | N/A | 161 | 307 |
| Inventories | N/A | N/A | N/A | 2,005 | 881 |
| TOTAL | $N/A | $N/A | $N/A | $3,624 | $1,568 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 3,395 | 3,845 |
| Other Non-Current Assets | 0 | 0 | 0 | 55 | 194 |
| TOTAL | $N/A | $N/A | $N/A | $3,450 | $4,039 |
| Total Assets | $N/A | $N/A | $N/A | $7,074 | $5,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 282 | 464 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 2,494 | 2,049 |
| TOTAL | $N/A | $N/A | $N/A | $3,830 | $2,579 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 986 | 45 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,532 | 1,448 |
| TOTAL | $N/A | $N/A | $N/A | $5,205 | $1,448 |
| Total Liabilities | $N/A | $N/A | $N/A | $9,034 | $4,027 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 5 | 5 |
| Retained earnings | N/A | N/A | N/A | -3,581 | 78 |
| Other shareholders' equity | 0 | 0 | 0 | -635 | -648 |
| TOTAL | $N/A | $N/A | $N/A | $-1,960 | $1,580 |
| Total Liabilities And Equity | $0 | $0 | $0 | $7,074 | $5,607 |